Using a Taxonomy to Systematically Identify and Describe Self-Management Interventions Components in Randomized Trials for COPD.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
04 10 2022
Historique:
received: 16 08 2022
revised: 26 09 2022
accepted: 30 09 2022
entrez: 14 10 2022
pubmed: 15 10 2022
medline: 18 10 2022
Statut: epublish

Résumé

Self-management interventions (SMIs) may improve outcomes in Chronic Obstructive Pulmonary Disease (COPD). However, accurate comparisons of their relative effectiveness are challenging, partly due to a lack of clarity and detail regarding the intervention content being evaluated. This study systematically describes intervention components and characteristics in randomized controlled trials (RCTs) related to COPD self-management using the COMPAR-EU taxonomy as a framework, identifying components that are insufficiently incorporated into the design of the intervention or insufficiently reported. Overall, 235 RCTs published between 2010 and 2018, from a systematic review were coded using the taxonomy, which includes 132 components across four domains: intervention characteristics, expected patient (or caregiver) self-management behaviours, patient relevant outcomes, and target population characteristics. Risk of bias was also assessed. Interventions mainly focused on physical activity (67.4%), and condition-specific behaviours like breathing exercise (63.5%), self-monitoring (50.8%), and medication use (33.9%). Support techniques like education and skills-training, self-monitoring, and goal setting (over 35% of the RCTs) were mostly used for this. Emotional-based techniques, problem-solving, and shared decision-making were less frequently reported (less than 15% of the studies). Numerous SMIs components were insufficiently incorporated into the design of COPD SMIs or insufficiently reported. Characteristics like mode of delivery, intensity, location, and providers involved were often not described. Only 8% of the interventions were tailored to the target population's characteristics. Outcomes that are considered important by patients were hardly taken into account. There is still a lot to improve in both the design and description of SMIs for COPD. Using a framework such as the COMPAR-EU SMI taxonomy may contribute to better reporting and to better informing of replication efforts. In addition, prospective use of the taxonomy for developing and reporting intervention content would further aid in building a cumulative science of effective SMIs in COPD.

Identifiants

pubmed: 36231985
pii: ijerph191912685
doi: 10.3390/ijerph191912685
pmc: PMC9566761
pii:
doi:

Types de publication

Journal Article Systematic Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Clin Med. 2020 Feb 28;9(3):
pubmed: 32121180
Int J Chron Obstruct Pulmon Dis. 2016 Aug 31;11:2063-74
pubmed: 27621612
Cochrane Database Syst Rev. 2014 Mar 19;(3):CD002990
pubmed: 24665053
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Respir Med. 2017 Aug;129:117-123
pubmed: 28732818
J Clin Epidemiol. 2021 Feb;130:13-22
pubmed: 33068715
PLoS One. 2019 Aug 1;14(8):e0220116
pubmed: 31369582
Health Psychol. 2008 May;27(3):379-87
pubmed: 18624603
PLoS One. 2021 Mar 1;16(3):e0247522
pubmed: 33647039
Health Res Policy Syst. 2021 Feb 10;19(1):17
pubmed: 33568139
Patient Educ Couns. 2021 Jan;104(1):50-63
pubmed: 32912809
BMJ Open. 2020 Jan 19;10(1):e034680
pubmed: 31959612
Lancet. 2011 Sep 10;378(9795):1015-26
pubmed: 21907865
J Thorac Dis. 2014 Nov;6(11):1615-31
pubmed: 25478202
Respir Res. 2013 Oct 20;14:109
pubmed: 24138097
Int J Chron Obstruct Pulmon Dis. 2017 Jun 08;12:1705-1720
pubmed: 28652723
Circulation. 2006 Sep 26;114(13):1432-45
pubmed: 16952985
Lancet. 2009 Aug 29;374(9691):733-43
pubmed: 19716966
Eur Respir J. 2016 Jul;48(1):46-54
pubmed: 27076595
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Chron Respir Dis. 2012 Feb;9(1):5-7
pubmed: 22308549
Implement Sci. 2015 Apr 23;10:55
pubmed: 25900104
Chron Respir Dis. 2012 Feb;9(1):27-35
pubmed: 22308551
Psychol Health. 2011 Nov;26(11):1479-98
pubmed: 21678185
PLoS Med. 2010 Sep 21;7(9):e1000326
pubmed: 20877712
J Clin Nurs. 2013 Mar;22(5-6):621-37
pubmed: 23398312
Patient Educ Couns. 2002 Oct -Nov;48(2):177-87
pubmed: 12401421
PLoS Med. 2014 Aug 12;11(8):e1001690
pubmed: 25117057
J Adv Nurs. 2017 Jun;73(6):1255-1271
pubmed: 27754557
BMJ. 2008 Jun 28;336(7659):1472-4
pubmed: 18583680
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Int J Chron Obstruct Pulmon Dis. 2016 Apr 07;11:739-46
pubmed: 27103797
Transl Res. 2013 Oct;162(4):208-18
pubmed: 23684710
Respirology. 2016 Jan;21(1):14-23
pubmed: 26494423
Addiction. 2012 Aug;107(8):1431-40
pubmed: 22340523
Health Expect. 2021 Oct;24(5):1626-1638
pubmed: 34252259
Int J Chron Obstruct Pulmon Dis. 2008;3(4):499-507
pubmed: 19281068
Health Psychol. 2014 May;33(5):465-74
pubmed: 23730717
BMJ. 2013 Sep 10;347:f3755
pubmed: 24021722
Chron Respir Dis. 2016 Feb;13(1):13-22
pubmed: 26396159

Auteurs

Monique Heijmans (M)

Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The Netherlands.

Rune Poortvliet (R)

Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The Netherlands.

Marieke Van der Gaag (M)

Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The Netherlands.

Ana I González-González (AI)

Avedis Donabedian Research Institute (FAD), 08037 Barcelona, Spain.
Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), 08025 Barcelona, Spain.
Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 28029 Madrid, Spain.

Jessica Beltran Puerta (J)

Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), 08025 Barcelona, Spain.

Carlos Canelo-Aybar (C)

Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), 08025 Barcelona, Spain.

Claudia Valli (C)

Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), 08025 Barcelona, Spain.

Marta Ballester (M)

Avedis Donabedian Research Institute (FAD), 08037 Barcelona, Spain.
Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), 08025 Barcelona, Spain.
Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 28029 Madrid, Spain.

Claudio Rocha (C)

Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), 08025 Barcelona, Spain.

Montserrat León Garcia (ML)

Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), 08025 Barcelona, Spain.

Karla Salas-Gama (K)

Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), 08025 Barcelona, Spain.

Chrysoula Kaloteraki (C)

Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), 08025 Barcelona, Spain.

Marilina Santero (M)

Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), 08025 Barcelona, Spain.

Ena Niño de Guzmán (E)

Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), 08025 Barcelona, Spain.

Cristina Spoiala (C)

Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The Netherlands.

Pema Gurung (P)

Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The Netherlands.

Saida Moaddine (S)

Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The Netherlands.

Fabienne Willemen (F)

Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The Netherlands.

Iza Cools (I)

Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The Netherlands.

Julia Bleeker (J)

Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The Netherlands.

Angelina Kancheva (A)

Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The Netherlands.

Julia Ertl (J)

Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The Netherlands.

Tajda Laure (T)

Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The Netherlands.

Ivana Kancheva (I)

Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The Netherlands.

Kevin Pacheco-Barrios (K)

Avedis Donabedian Research Institute (FAD), 08037 Barcelona, Spain.
Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), 08025 Barcelona, Spain.

Jessica Zafra-Tanaka (J)

Avedis Donabedian Research Institute (FAD), 08037 Barcelona, Spain.
Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), 08025 Barcelona, Spain.

Dimitris Mavridis (D)

Department of Primary Education, School of Education, University of Ioannina, 45110 Ioannina, Greece.

Areti Angeliki Veroniki (A)

Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON M5B 1W8, Canada.
Institute for Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON M5S 3G8, Canada.

Stella Zevgiti (S)

Department of Primary Education, School of Education, University of Ioannina, 45110 Ioannina, Greece.

Georgios Seitidis (G)

Department of Primary Education, School of Education, University of Ioannina, 45110 Ioannina, Greece.

Pablo Alonso-Coello (P)

Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), 08025 Barcelona, Spain.

Oliver Groene (O)

OptiMedis, 20095 Hamburg, Germany.

Rosa Sunol (R)

Avedis Donabedian Research Institute (FAD), 08037 Barcelona, Spain.
Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), 08025 Barcelona, Spain.

Carola Orrego (C)

Avedis Donabedian Research Institute (FAD), 08037 Barcelona, Spain.
Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), 08025 Barcelona, Spain.
Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 28029 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH